EFNA1 and breast cancer: In breast cancer model systems, Ephrin-A1 signaling through the EphA2 receptor on the tumor cell can inhibit tumorigenesis [89,90], whereas excess unliganded EphA2 promotes tumorigenesis through enhanced proliferation and migration [90,91].